K2 Principal Fund’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

K2 Principal Fund’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-104,080	Closed	-$18M	–	237
2015 Q1	$18M	Buy	+104,080	New	+$15.3M	3.79%	4

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

K2 Principal Fund's SLXP Position: Q2 2015 in Review

K2 Principal Fund sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 104,080 shares — an estimated $18M sold.

K2 Principal Fund first reported a position in SLXP in Q1 2015 and held it in 1 quarter. The position peaked at $18M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

K2 Principal Fund reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
K2 Principal Fund sold 104,080 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $18M.
K2 Principal Fund first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2015 and held it in 1 quarter.
K2 Principal Fund's SALIX PHARMACEUTICALS LTD DEL position peaked at $18M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on K2 Principal Fund's 13F filing for Q2 2015, filed 29 Jul 2015.